An interview with Feng Shao and Weihong Tan: chemistry intertwines with biology and medicine

Weijie ZhaoNational 2019 · DOI

TL;DR

This interview highlights how chemistry provides essential conceptual frameworks and practical tools for advancing biomedical science. Two leading researchers, Feng Shao (immunology) and Weihong Tan (bioanalytical chemistry), discuss their shared vision of solving health problems by understanding molecular mechanisms and the crucial role of chemistry in this endeavor.

What Problem Does This Paper Address?

The paper addresses the fundamental question of how chemistry underpins and drives progress in biology and medicine. It explores the synergy between these fields, emphasizing that understanding complex biological processes and developing effective treatments requires a deep dive into molecular mechanisms, which is inherently a chemical pursuit. The interview also touches upon the challenges and opportunities in translating basic research into clinical applications, particularly in the context of China's evolving biomedical landscape.

Methods

This paper is an interview, not a research paper with experimental methods. However, the researchers discuss several key areas and approaches:

  • Molecular Biology Methods: Gene editing and antigen-antibody recognition (e.g., immunohistochemistry) are mentioned as foundational biological techniques.
  • Chemistry-Based Tools: The interview emphasizes the extensive use of chemical probes, intervention reagents, and other chemical tools that have significantly benefited life science research.
  • Bioanalytical Chemistry & Chemical Biology: Professor Tan's work involves developing DNA-based molecular tools, such as aptamers, which are short DNA molecules designed to recognize specific antigens. These are then chemically optimized for stability and in vivo applications.
  • Computational Methods: Artificial intelligence and bioinformatics are discussed as tools for designing screening libraries and identifying optimal molecular sequences.
  • Translational Research: The researchers discuss the process of moving from basic discoveries to clinical applications, involving collaboration with industry, clinical trials, and the development of diagnostic and therapeutic agents.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Chemistry as the "Mechanism" Provider: Chemistry introduced the concept of "mechanism" into life sciences, enabling researchers to understand biological processes at the molecular level.
  • Biology Relies on Chemical Tools: While biology has its core methods, it heavily depends on tools and technologies developed by chemistry, physics, and other disciplines.
  • The Human Body as a Molecular Machine: Both scientists view the human body as a complex molecular machine, where diseases arise from abnormalities in molecular interactions.
  • Evolutionary Arms Race: The interaction between pathogens and hosts is framed as an ongoing evolutionary fight, with both sides developing sophisticated molecular strategies.
  • The Power of Aptamers: DNA-based aptamers offer a promising avenue for developing novel molecular recognition probes for diagnostics and therapeutics, acting as chemical alternatives to antibodies.
  • Bridging Basic Science and Clinic: The interview highlights the critical need for interdisciplinary collaboration and strategic planning to translate fundamental discoveries into tangible clinical benefits.
  • "Happy Research": Professor Tan advocates for pursuing research that is enjoyable and meaningful, believing this fosters creativity and optimal outcomes.

Key Results

As an interview, this paper does not present quantitative results. However, it discusses the potential and progress in several areas:

  • Understanding Septic Shock: Research on caspase-11 and gasdermin-D has shed light on Gram-negative bacteria-induced septic shock.
  • Aptamer Drug Conjugates (ApDCs): Professor Tan's lab has developed four ApDCs that are in the early stages of clinical trials.
  • Translational Efforts: Both researchers are actively involved in collaborations and studies aimed at moving their discoveries towards clinical application, with Shao mentioning potential targets for anti-inflammatory agents and cancer immunotherapy.

Limitations and Future Work

  • Understanding Gram-Positive Sepsis: While Gram-negative sepsis is better understood, the mechanisms of sepsis caused by Gram-positive bacteria and fungi remain largely unknown.
  • Unidentified Innate Immune Receptors: The vast diversity of bacterial pathogens suggests that many more innate immune receptors are yet to be discovered.
  • System-Level Understanding of Immunity: A significant challenge remains in understanding the anti-bacterial immune responses and their pathological significance at a systemic level in animals.
  • Challenges in Small Molecule-Protein Interaction Discovery: Identifying proteins that functionally bind to small molecules (like lipids or sugars) is more difficult than the reverse.
  • Reproducibility in Biomedical Research: While Shao finds reproducibility good in his field, the general challenge of reproducibility in biomedical research, especially in complex areas like cancer, is acknowledged. Tan notes that chemical research is often more reproducible than biological experiments due to system complexity and reagent variability.
  • Clinical Trial Success Rates: Tan acknowledges that the success rate of clinical trials is low, making it difficult to predict when new tools will be widely applied.
  • China's Regulatory Landscape: While improving, China's drug approval process is still evolving, and the CFDA was historically cautious.
  • Need for Expert Clinicians: Shao emphasizes the critical need for excellent clinical scientists to design and lead clinical trials for new drugs.
  • Future Directions: Both researchers plan to continue exploring immune recognition mechanisms, pyroptosis, and developing molecular tools for diagnosis and treatment. Tan aims to integrate molecular and medical science for first-in-class drugs and pattern recognition-based diagnostics. Shao is interested in Gram-positive bacteria and the role of pyroptosis in diseases like cancer.

Summary updated

Abstract

Professor Feng Shao at National Institute of Biological Sciences, Beijing is a well-known immunologist. He has made a series of fundamental contributions to the fields of pathogen-host interactions and innate immune response mechanisms. Professor Weihong Tan at Hunan University and Shanghai Jiaotong University is a world-renowned scholar in bioanalytical chemistry and chemical biology. He developed a number of chemical tools that expended the extent of molecular medicine and may turn into useful clinical diagnosis and treatment tools. In May 2019, National Science Review (NSR) had an interview with Professors Feng Shao and Weihong Tan. The two scientists, both trained at University of Michigan for their PhD study, have different research directions, but share the same basic scientific vision: to solve human health-related fundamental problems by illuminating and making use of the underlying molecular mechanisms. They also share similar opinions on biomedical research methods and scientific career development.
BibTeX
@inproceedings{zhao2019interview,
  author = {Weijie Zhao},
  title = {{An interview with Feng Shao and Weihong Tan: chemistry intertwines with biology and medicine}},
  booktitle = {National},
  year = {2019},
  doi = {10.1093/nsr/nwz165},
}
Figure